scholarly journals Men’s Experiences of Sex and Intimacy After Prostate Cancer Treatment In China: A Qualitative Study

2021 ◽  
Author(s):  
Tong Wang ◽  
Hui-Lin Cheng ◽  
Ping Kit Kitty Wong ◽  
Wen Dong
Keyword(s):  
Prostate Cancer ◽  
Sexual Health ◽  
Healthcare Providers ◽  
Comparison Analysis ◽  
Prostate Cancer Treatment ◽  
Telephone Interviews ◽  
Outpatient Unit ◽  
Health Support ◽  
Asian Context ◽  
The Impact

Abstract Purpose While the existing knowledge base on the impact of prostate cancer (PC) and its treatment on sexuality and intimacy has been generated from Western populations, there is a lack of such evidence in the Asian context. This study aimed to explore men’s experiences of sex and intimacy after PC treatment in China. Methods This study adopted an interpretive descriptive design. Using purposive sampling, 13 PC patients were selected from a urology outpatient unit of a hospital in South China and proceeded with individual semi-structured telephone interviews. Each interview was transcribed verbatim and analyzed using constant comparison analysis. Results Four themes emerged from the interview data, including (a) encountering altered sexuality, (b) communication and sexual adjustments, (c) maintenance of quality intimate relationship, and (d) lack of sexual health support. Conclusions The findings revealed that PC treatment significantly impaired patients’ sexual functions, and their sexual health needs were mainly unmet by healthcare providers. There is a great need to design culturally relevant interventions to improve sexual health among this population.

The impact of prostate volume changes during external-beam irradiation in consequence of HDR brachytherapy in prostate cancer treatment

2009 ◽  
Vol 185 (6) ◽  
pp. 397-403 ◽  
Author(s):  
Markus Karl Alfred Herrmann ◽  
Tammo Gsänger ◽  
Arne Strauss ◽  
Tereza Kertesz ◽  
Hendrik A. Wolff ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Treatment ◽  
Prostate Volume ◽  
External Beam ◽  
Hdr Brachytherapy ◽  
Beam Irradiation ◽  
Volume Changes ◽  
Prostate Cancer Treatment ◽  
External Beam Irradiation ◽  
The Impact

scholarly journals Ejaculatory and Orgasmic Dysfunction Following Prostate Cancer Therapy: Clinical Management

2019 ◽  
Vol 7 (12) ◽  
pp. 109
Author(s):  
Travis P. Green ◽  
Jose Saavedra-Belaunde ◽  
Run Wang
Keyword(s):  
Prostate Cancer ◽  
Erectile Dysfunction ◽  
Sexual Health ◽  
Cancer Treatment ◽  
Sexual Life ◽  
Management Options ◽  
Prostate Cancer Treatment ◽  
Prostate Cancer Therapy ◽  
Pubmed Search ◽  
Orgasmic Dysfunction

The majority of sexual health research has focused on erectile dysfunction following prostate cancer treatment. Ejaculatory and orgasmic dysfunction are significant side effects following the treatment of prostate cancer. Orgasmic dysfunction covers a range of issues including premature ejaculation, anorgasmia, dysorgasmia, and climacturia. This review provides an overview of prevalence and management options to deal with orgasmic dysfunction. A Medline Pubmed search was used to identify articles relating to these problems. We found that orgasmic dysfunction has a very large impact on patients’ lives following prostate cancer treatment and there are ways for physicians to treat it. Management of patients’ sexual health should be focused not only on erectile dysfunction, but on orgasmic dysfunction as well in order to ensure a healthy sexual life for patients and their partners.

The Impact of Socioeconomic Status on Prostate Cancer Treatment and Survival in the Southern Netherlands

Urology ◽  
2013 ◽  
Vol 81 (3) ◽  
pp. 593-601 ◽  
Author(s):  
Mieke J. Aarts ◽  
Evert L. Koldewijn ◽  
Philip M. Poortmans ◽  
Jan Willem W. Coebergh ◽  
Marieke Louwman
Keyword(s):  
Prostate Cancer ◽  
Socioeconomic Status ◽  
Cancer Treatment ◽  
Prostate Cancer Treatment ◽  
Southern Netherlands ◽  
The Impact

The impact of within-visit and pre-visit decision aids for localized prostate cancer on patient knowledge.

2020 ◽  
Vol 38 (29_suppl) ◽  
pp. 151-151
Author(s):  
Jon Charles Tilburt ◽  
Joel E Pacyna ◽  
Kristin Cina ◽  
Daniel G. Petereit ◽  
Judith Salmon Kaur ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Linear Regression ◽  
Cancer Treatment ◽  
Usual Care ◽  
Decision Aid ◽  
Decision Aids ◽  
Specific Antigen ◽  
Patient Knowledge ◽  
Prostate Cancer Treatment ◽  
The Impact

151 Background: Decision aids (DAs) for prostate cancer treatment can improve knowledge and reduce decisional conflict, but the relative effect of pre-visit and within-visit DAs is not known, and effect sizes for minority populations has not been estimated. Methods: We conducted a 3-arm, patient-level-RCT in specialty urology and radiation oncology practices in Ohio, South Dakota, and Alaska, test the effect of pre-consultation and with-in consultation decision aids on patient knowledge immediately after specialty consultation compared to usual care. We used linear regression to estimate effects of each intervention arm, including the respective standard error, two-sided 95% confidence interval, and two-sided P value for testing the study’s hypotheses. Results: 103 patients were recruited and randomized to receive either the pre-visit decision aid, within-visit decision aid, or neither decision aids (usual care). In 2017 and 20018, we accrued similar numbers of men to pre-consultation aid (n = 37), during-consultation aid (n = 33) and usual care arms, respectively (n = 33). The median (range) age in years was 64 [49, 81]; 67.6% were White, 15.7% were Black or African American, 16.7% were American Indian or Alaska Native, and 1% were not reported. 47.6%, 45.6%, and 6.8% had a baseline clinical stage of T1, T2, and T3, respectively. The median [range] prostate specific antigen (PSA) was 8.0 [2.4, 53.7]. There were no clinically notable imbalances. We obtained usable data on 102 of the 103 patient-participants. The pre-visit decision aid arm showed a mean knowledge effect of 0.694 (0.636, 0.753). The within-visit decision arm showed a very similar mean knowledge effect of 0.686 (0.625, 0.748). The usual care arm showed a mean knowledge effect of 0.644 (0.582,0.705). The linear regression model showed, that, compared with usual care, neither intervention effect achieved statistical significance in the primary analysis (p = 0.24, 0.330, for pre-visit and within-visit, respectively). Conclusions: Modest knowledge gains of pre-visit and during-visit decision aids for prostate cancer treatment were not statistically significant. Clinical trial information: NCT03182998 .

scholarly journals Prostate Cancer Treatment and Work: A Scoping Review

2020 ◽  
Vol 14 (6) ◽  
pp. 155798832097925
Author(s):  
Wellam F. Yu Ko ◽  
John L. Oliffe ◽  
Joan L. Bottorff
Keyword(s):  
Prostate Cancer ◽  
Return To Work ◽  
Cancer Treatment ◽  
Scoping Review ◽  
Current Knowledge ◽  
Significant Proportion ◽  
Future Research ◽  
Prostate Cancer Treatment ◽  
Work Lives ◽  
The Impact

Prostate cancer is the most common malignancy diagnosed in North American men. Although medical advances have improved survival rates, men treated for prostate cancer experience side-effects that can reduce their work capacity, increase financial stress, and affect their career and/or retirement plans. Working-age males comprise a significant proportion of new prostate cancer diagnoses. It is important, therefore, to understand the connections between prostate cancer and men’s work lives. This scoping review aimed to summarize and disseminate current research evidence about the impact of prostate cancer treatment on men’s work lives. Electronic databases were searched to identify peer-reviewed articles published between 2006 and 2020 that reported on the impact of prostate cancer treatment on men’s work. Following scoping review guidelines, 21 articles that met inclusion criteria were identified and analyzed. Evidence related to the impact of prostate cancer on work was grouped under three themes: (1) work outcomes after prostate cancer treatment; (2) return to work considerations, and (3) impact of prostate cancer treatment on men’s finances. Findings indicate that men’s return to work may be more gradual than expected after prostate cancer treatment. Some men may feel pressured by financial stressors and masculine ideals to resume work. Diverse factors including older age and social benefits appear to play a role in shaping men’s work-related plans after prostate cancer treatment. The findings provide direction for future research and offer clinicians a synthesis of current knowledge about the challenges men face in resuming work in the aftermath of prostate cancer treatment.

A Call to Arms: Increasing Our Understanding of the Impact of Prostate Cancer on the Sexual Health of Partners

2020 ◽  
Vol 17 (3) ◽  
pp. 361-363
Author(s):  
Stacy Loeb ◽  
Carolyn A. Salter ◽  
Christian J. Nelson ◽  
John P. Mulhall ◽  
Daniela Wittmann
Keyword(s):  
Prostate Cancer ◽  
Sexual Health ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document